A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, yet therapy is often hampered by immune-related adverse events (irAEs) which range from mild to severe life-threatening events. Musculoskeletal (MSK) irAEs leading to discontinuation of ICIs are uncommon but increasingl...
Main Authors: | Bicky Thapa, Asad Ali, Raunak Nair, Rishik Vashisht, Cassandra Calabrese |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2019/1326734 |
Similar Items
-
Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
by: Ammar Haikal, et al.
Published: (2018-01-01) -
Psoriatic arthritis due to nivolumab administration a case report and review of the literature
by: Konstantinos Sapalidis, et al.
Published: (2018-01-01) -
Skin in rheumatoid arthritis and seronegative arthritis
by: Pragathi Sankineni, et al.
Published: (2019-01-01) -
Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis
by: Shin-ya Kawashiri, et al.
Published: (2019-01-01) -
Radiographic estimation in seropositive and seronegative rheumatoid arthritis
by: Vjollca Sahatçiu-Meka, et al.
Published: (2011-08-01)